A. Martínez Monzonís

Classification, prevalence, and outcomes of anticancer therapy-induced cardiotoxicity: the CARDIOTOX registry

José López‐Sendón, Carlos Álvarez-Ortega, Pilar Auñón et al. · European Heart Journal · 2020 · 284 citations · Full text

Medicine, Cardiology, Oncology +17

Sildenafil for improving outcomes in patients with corrected valvular heart disease and persistent pulmonary hypertension: a multicenter, double-blind, randomized clinical trial

Javier Bermejo, Raquel Yotti, Rocío García‐Orta et al. · European Heart Journal · 2017 · 226 citations · Full text

Medicine, Cardiology, Pharmacotherapy +10

Cardiovascular risk factors during cancer treatment. Prevalence and prognostic relevance: insights from the CARDIOTOX registry

Juan Caro‐Codón, Teresa López‐Fernández, Carlos Álvarez-Ortega et al. · European Journal of Preventive Cardiology · 2020 · 63 citations

Medicine, Cardiology, Oncology +17

Anthracycline-induced cardiovascular toxicity: validation of the Heart Failure Association and International Cardio-Oncology Society risk score

Borja Rivero Santana, Jesús Saldaña García, Juan Caro‐Codón et al. · European Heart Journal · 2024 · 50 citations · Full text

Medicine, Cardiology, Oncology +16

Worldwide Disparities in Recovery of Cardiac Testing 1 Year Into COVID-19

Andrew J. Einstein, Cole B. Hirschfeld, Michelle A. Williams et al. · Journal of the American College of Cardiology · 2022 · 32 citations · Full text

Medicine, Cardiology, Health Sciences +13